Part of the working group of leaders in global surgery representing major institutions which Kletjian Foundation collaborates with on a regular basis.

CABINET MEMBER

Part of the working group of leaders in global surgery representing major institutions which Kletjian Foundation collaborates with on a regular basis.

Dr. James Cusack

Massachusetts General Hospital

James Cusack, MD, FACS, is a graduate of Dartmouth College and Emory University Medical School who trained in general surgery at Tufts-New England Medical Center. He completed a Research Fellowship at Brigham and Women's Hospital and a Surgical Oncology Fellowship at MD Anderson Cancer Center. In 2000 he joined the staff at Massachusetts General, the faculty of Harvard Medical School, and the consulting staff at Dana-Farber Cancer Institute. At Massachusetts General, Dr. Cusack is Director of the Peritoneal Surface Malignancy (HIPEC) Program. He served on the Executive Council of the Society of Surgical Oncology (SSO) and was Chair of the SSO Scientific Program Committee. He also served on the American Society of Clinical Oncology Gastrointestinal Symposium Program Committee. Among Dr. Cusack's awards for his patient care are Boston Super Doctors, Boston Top Doctors, The MGH One Hundred, America's Top Surgeons, America's Top Doctors for Cancer, and Patients' Choice Award.

 

The Cusack Laboratory has made landmark contributions to the understanding of molecular mechanisms of chemotherapy resistance. Since 1995 Dr. Cusack's research has been funded by NIH, American Cancer Society, biotech, and his patients. Ongoing 

research topics are biomarkers of resistance and new targets for therapeutic intervention in colorectal and appendiceal cancer, melanoma, and Merkel Cell carcinoma. His bibliography lists over 70 publications, and he serves on numerous editorial boards. Currently, Dr. Cusack is the Director of the MGH Global Surgery Initiative and Co-Chair of the MGH Cancer Center Global Health Committee. He leads the MGH Cancer Care Initiative in Mbarara, Uganda, and is committed to improving access to affordable surgical treatment and multidisciplinary cancer care in resource-limited settings, especially the East African Community.

Learn more about Dr. Cusack, his clinical interests, and his research here: